DCS Pharma USA
SAVE TIME AND MONEY
From A-Z of your project, one person will take care of all your needs. Got technical questions? Regulatory issues? You can count on our Swiss experts and their worldwide network.
STAY ON THE SAVE SIDE
The sourcing of oncology API from Asia incurs uncertainties, that can be out of your control. Being a Swiss owned company that is active in the market for more than 100 years, stability is our central focus. That's why we accept full responsibility throughout the project - so that you can focus on your core business.
A BROAD PORTFOLIO
We focus on the following theapeutic groups:
Download our porfolio as PDF file.
In addition, you can rely on a comprehensive service: Regulatory affairs, sourcing, patent clarifications and independent GMP audits at Asian manufacturers are carried out in proven Swiss quality. So you're on the safe side.
DCS Pharma USA
801 Brickell Ave, Suite 900
Fl-33131 Miami - Florida
United States of America
Tel: +1 305 789 6647
Fax: +1 305 372 0189
DAPAGLIFLOZIN FROM DCS PHARMA USA: BREAKTHROUGH FOR TYPE-2 DIABETES
We are pleased to introduce Dapagliflozin for the treatment of type-2 diabetes, another DCS Pharma USA solution to maximize your sourcing results.
PEMETREXED: MAXIMIZE YOUR SOURCING RESULTS
Let's face it - sourcing of oncology API from Asia can be difficult. Hence, DCS Pharma USA is proud to introduce new solutions that will maximize your sourcing results.
MARCH 19-22, 2018
NEW YORK, USA
Save time and money - and be first in the market. Let's talk about your plans.
MAY 24-26, 2018
PENNSYLVANIA CONVENTION CENTER
Learn more about our commitment to API. Contact us for an appointment.